The Cost-Effectiveness of Biologic Dmards in Patients With Severe or Mild-To-Severe Rheumatoid Arthritis After Conventional Dmards
Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.2611
https://www.valueinhealthjournal.com/article/S1098-3015(14)04560-4/fulltext
Section Title :
Disease-Specific Studies
Section Order :
317
First Page :
A380
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04560-4&doi=10.1016/j.jval.2014.08.2611